Sotera Health (NASDAQ:SHC – Get Free Report) will likely be issuing its Q3 2026 results before the market opens on Tuesday, November 3rd. Analysts expect Sotera Health to post earnings of $0.2687 per share and revenue of $319.86 million for the quarter. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 9:00 AM ET.
Sotera Health (NASDAQ:SHC – Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. The business had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. During the same period last year, the business posted $0.20 EPS. Sotera Health’s revenue was up 9.2% on a year-over-year basis. On average, analysts expect Sotera Health to post $0.87 EPS for the current fiscal year and $0.95 EPS for the next fiscal year.
Sotera Health Trading Up 1.6%
Sotera Health stock opened at $18.39 on Tuesday. The stock has a 50-day simple moving average of $18.56 and a 200 day simple moving average of $17.05. The stock has a market capitalization of $5.25 billion, a P/E ratio of 21.29 and a beta of 1.85. The company has a debt-to-equity ratio of 3.33, a quick ratio of 2.55 and a current ratio of 2.80. Sotera Health has a 52 week low of $13.09 and a 52 week high of $19.85.
Insider Buying and Selling
In other news, insider Michael Rutz sold 150,000 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider owned 334,279 shares in the company, valued at approximately $6,297,816.36. This trade represents a 30.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Michael Petras, Jr. sold 850,000 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 1,294,515 shares of company stock valued at $23,999,528. Corporate insiders own 15.36% of the company’s stock.
Analyst Ratings Changes
A number of research firms have recently issued reports on SHC. Citigroup raised their price objective on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Weiss Ratings cut Sotera Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday. Barclays raised their price target on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price objective on shares of Sotera Health in a report on Tuesday, September 8th. Finally, JPMorgan Chase & Co. reiterated an “underweight” rating and issued a $17.00 price objective on shares of Sotera Health in a report on Wednesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $21.38.
View Our Latest Stock Analysis on Sotera Health
About Sotera Health
Sotera Health Company (NASDAQ: SHC) is a healthcare services company focused on sterilization, laboratory testing and infection prevention. Its services support manufacturers and providers across the medical device, pharmaceutical, tissue, food safety and other healthcare-related industries.
The company operates through three primary businesses. Sterigenics provides outsourced sterilization services, including ethylene oxide, gamma irradiation and electron-beam processing. Nelson Labs offers laboratory testing, analytical services and consulting for medical devices, pharmaceuticals and other healthcare products.
Featured Articles
- Five stocks we like better than Sotera Health
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
